Status:
UNKNOWN
STUDY OF SURVIVAL AND FUNCTIONALITY IN CRYOPRESERVED PLATELETS
Lead Sponsor:
HOSPITAL BRITANICO DE BUENOS AIRES
Conditions:
Platelet Cryopreservation
Platelet Survival
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Platelets correspond to one of the most widely used blood components in transfusion medicine, given their importance in the prevention of bleeding disorders in patients with multifactorial thrombocyto...
Detailed Description
HYPOTHESIS: Through cryopreservation it is possible to prolong the survival time of platelets up to 4 times, compared to those preserved under the conventional method, maintaining a viability equal to...
Eligibility Criteria
Inclusion
- Concentrates from donors over 18 years of age who meet the requirements established by law 22990 for donating blood and blood components will be included in this study, from whom a number of platelets greater than or equal to 3 x10 E11 can be collected
Exclusion
- Platelet concentrates that present any of the following characteristics will be excluded from the investigation:
- Concentrates that have not met all of the standards required for use in humans or that at the time of the study more than 24 hours have passed since they were obtained.
Key Trial Info
Start Date :
February 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 2 2022
Estimated Enrollment :
281 Patients enrolled
Trial Details
Trial ID
NCT04754841
Start Date
February 3 2021
End Date
February 2 2022
Last Update
August 3 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Britanico Buenos Aires
Buenos Aires, Argentina, 1082
2
Hospital Britanico de Buenos Aires
Buenos Aires, Argentina, 1406